EMR
February 7, 2024 - AI Summary
Overvalued by 70.3% based on the discounted cash flow analysis.
Market cap | $64.36 Billion |
---|---|
Enterprise Value | $72.81 Billion |
Dividend Yield | $2.0796 (1.85%) |
Earnings per Share | $18.7 |
Beta | 0.87 |
Outstanding Shares | 572,100,000 |
Avg 30 Day Volume | 3,252,759 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 6.0 |
---|---|
PEG | -16.32 |
Price to Sales | 3.96 |
Price to Book Ratio | 3.08 |
Enterprise Value to Revenue | 4.4 |
Enterprise Value to EBIT | 29.43 |
Enterprise Value to Net Income | 6 |
Total Debt to Enterprise | 0.15 |
Debt to Equity | 0.52 |
No data
No data